Skip to main content
. Author manuscript; available in PMC: 2006 Feb 3.
Published in final edited form as: Ann Allergy Asthma Immunol. 2004 Apr;92(4):420–425. doi: 10.1016/S1081-1206(10)61777-2

Table 3.

Medians (Range) of Asthma Morbidity Variables between Intervention and Control*

Group Baseline Month 2 Month 5
Intervention
    Albuterol use in past 2 weeks, d 7 (1–14) 4 (0–14) 2 (0–14)
    No. of nights when caregiver lost sleep in past 2 weeks 1 (0–14) 0 (0–5) 0 (0–6)
    No. of school days missed in past 3 months 1 (0–5) 2 (0–4) 0 (0–6)
    No. of days of wheezing in past 2 weeks 2 (0–7) 2 (0–6) 1 (0–14)
Control
    Albuterol use in past 2 weeks, d 3.5 (2–14) 3.5 (0–7) 1 (0–14)
    No. of nights when caregiver lost sleep in past 2 weeks 1.5 (0–8) 0.5 (0–3) 1.5 (0–2)
    No. of School days missed in past 3 months 0.5 (0–2) 1 (0–2) 1 (0–2)
    No. of days of wheezing in past 2 weeks 2.5 (0–14) 2.6 (0–6) 2 (0–7)
*

No statistically significant differences were indicated for any of these morbidity variables.

HHS Vulnerability Disclosure